Sun Pharmaceuticals Industries reports standalone net loss of Rs 906.42 crore in the September 2018 quarter

Sales rise 25.29% to Rs 2217.42 crore

Net loss of Sun Pharmaceuticals Industries reported to Rs 906.42 crore in the quarter ended September 2018 as against net profit of Rs 577.05 crore during the previous quarter ended September 2017. Sales rose 25.29% to Rs 2217.42 crore in the quarter ended September 2018 as against Rs 1769.86 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales2217.421769.86 25 OPM %2.69-4.72 -PBDT441.23678.71 -35 PBT318.87573.63 -44 NP-906.42577.05 PL

Powered by Capital Market - Live News